Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsrespiratory-sleep-and-airway

Paeds SAQs · respiratory-sleep-and-airway

Respiratory manifestations of systemic disease — short-answer question

Short-answer question on recognising and managing lung involvement in systemic disease in a child, anchored on sickle cell acute chest syndrome, with the disease-specific reflex across connective tissue disease, immunodeficiency, and malignancy.

20 marks30 min2 min readVerification in progress

Target exams

RACP DWEMRCPCH TheoryABP General Pediatrics
On this page
Study tools

Target exams

RACP DWEMRCPCH TheoryABP General Pediatrics
Prompt
A 9-year-old boy with known homozygous sickle cell disease is admitted with a severe painful crisis affecting his back and limbs. On day two of admission he develops a fever of 38.8 degrees, pleuritic chest pain, a cough, and an oxygen saturation that has fallen to 91 percent in air. A chest radiograph now shows a new left lower lobe infiltrate that was not present on admission. Outline how you would recognise and explain his problem, your acute management, and how you would reduce his future risk; then describe the general reflex you would apply to a child with any systemic disease who develops new respiratory signs.

Part A — Recognition and mechanism (10 marks)

a) State the diagnosis and how you recognise it (3 marks)

This boy has acute chest syndrome, defined by a new pulmonary infiltrate on chest imaging together with fever and respiratory signs — here pleuritic chest pain, cough, and hypoxia. The classic and dangerous timing is that it has evolved on day two of admission for a painful crisis rather than being present at arrival, which is exactly when vigilance drops. It is the leading cause of death in sickle cell disease, so it is recognised early and treated presumptively rather than after the full picture completes. [1] [2]

b) Explain the underlying mechanism (4 marks)

Acute chest syndrome is a self-amplifying vicious cycle. A trigger such as infection, a fat embolus from infarcting bone marrow, or pain-driven hypoventilation lowers oxygen, low oxygen promotes sickling in the pulmonary vessels, sickling causes vaso-occlusion and further infarction, and the resulting inflammation and atelectasis worsen oxygenation, which drives yet more sickling. His painful crisis and splinting from chest pain feed directly into this loop. [2] [1]

c) State why prompt action matters (3 marks)

The syndrome can progress within hours from a stable child to respiratory failure, and it is the commonest reason for intensive care and the leading cause of death in this group. Because pneumonia and pulmonary infarction coexist with it and are managed together, over-treating is far safer than trying to exclude it, so early aggressive treatment is the correct response to even an incomplete picture. [1] [2]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [1]Vichinsky EP, Neumayr LD, Earles AN, et al Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med, 2000.PMID 10861320
  2. [2]Ramirez V, Mercier-Ross J Acute Chest Syndrome in Children with Sickle Cell Disease: A Narrative Review. Children (Basel), 2026.PMID 42194196
  3. [3]Steinberg MH, Barton F, Castro O, et al Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA, 2003.PMID 12672732
  4. [4]Rice RR, Willen SM Supportive care, prevention, and emerging therapies for acute chest syndrome in sickle cell disease. Expert Rev Hematol, 2026.PMID 42446872
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousRespiratory distress and failure in children — formative SAQsrespiratory-sleep-and-airwayNextSpirometry and paediatric pulmonary-function testing — formative SAQsrespiratory-sleep-and-airway